BLFS Financial Facts
Total operating expenses: 2.35MResearch and development: 496.87K
See Full Income Statement
Total current liabilities: 3.46M
Less: Accumulated depreciation: -1.59M
See Full Balance Sheet
BioLife Solutions (BLFS) Earnings
|
Expand Research on BLFS
| Next EPS Date | 5/9/24 | EPS Growth Rate | -6.3% |
|---|---|---|---|
| Average EPS % Beat Rate | -34.1% | Revenue Growth Rate | -27.3% |
| Average % Move 1-Wk after EPS | -2.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/9/23 | Q323 | -$0.67 | -$0.36 | -$0.31 | $33.3M | $33.01M | = |  | | Details | |
| 2/28/22 |  |
Q421 | -$0.37 | -$0.17 | -$0.20 | $37.3M | $35.81M | = | | | Details |
| 5/10/23 | Q123 | -$0.32 | -$0.21 | -$0.11 | $37.7M | $42.92M | = | | | Details | |
| 2/29/24 | Q423 | -$0.30 | -$0.34 | +$0.04 | $32.7M | $33.4M | = | | | Details | |
| 3/9/17 | |
Q416 | -$0.26 | -$0.07 | -$0.19 | $2.25M | $2.23M | = | | | Details |
| 8/8/23 | Q223 | -$0.23 | -$0.21 | -$0.02 | $39.5M | $43.64M | = | | | Details | |
| 11/9/22 | Q322 | -$0.23 | -$0.16 | -$0.07 | $40.7M | $42.02M | = | | | Details | |
| 11/11/21 | |
Q321 | -$0.20 | -$0.09 | -$0.11 | $33.8M | $31.61M | = | | | Details |
